ZIOPHARM Oncology, Inc. to Present at the 22nd Annual Roth OC Growth Stock Conference

NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that Jonathan Lewis, MD, PhD, Chief Executive Officer, will present at the 22nd Annual Roth OC Growth Stock Conference on Monday, March 15, 2010 at 4:00 pm PT at the Ritz Carlton / Laguna Niguel, CA. Dr. Lewis will provide an overview of the Company and its clinical development programs.

MORE ON THIS TOPIC